NCT07855627Recruiting
Prediction Of Lymphedema In Patients With Inflammatory BreastCancer Using Preoperative Bioimpedance Measurements
M.D. Anderson Cancer Center
Start Date
9/16/2026
Completion Date
12/31/2029
Summary
To find out whether the BIA test can help identify participants with IBC who are at risk for developing lymphedema.
Detailed Description
Primary Objectives The primary objective is to reliably describe risk factors for development of BCRL in IBC using BIA.
Eligibility Criteria
Age Range: 18 years to No maximum
Eligibility Criteria All women≥18 years old with newly diagnosed inflammatory breast cancer without prior breast/axillary surgery who are eligible for standard of care (NST, MRM, and radiation therapy).
Exclusion Criteria Prior breast/axillary surgery. Participants with pacemakers or other implanted electronic medical devices. Participants with implanted metallic material. All vulnerable populations, including children, pregnant women, and cognitively impaired adult
Interventions
DRUG
Neoadjuvant therapy
Conditions
LymphedemaInflammatory Breast Cancer (IBC)PreoperativeBioimpedance Measurement
Locations
UT MD Anderson Cancer Center
Houston, Texas 77030
United States